Empowered by AI, TOP Biotechnology leading the new future of biotechnology and health
Top Biotechnology has a diversified business layout, comprehensively covering information services for Internet pharmaceuticals and medical devices. At the same time, it has demonstrated outstanding professional capabilities in technology promotion, development, transfer, consultation and service, continuously empowering the innovative development of the industry.In the software field, software development and application software services meet the needs of different customers in health management, data analysis and other aspects. In addition, the company conducts health management business, launches health food, and provides all-round health services. In terms of product sales, the company provides Class I and II medical devices and laboratory equipment to assist medical institutions and scientific research units in their work.
Top Biotechnology adheres to innovation-driven development. With a professional scientific research team and a complete R&D system, it has developed a series of detection technologies and products with international advanced levels. The company's non-invasive blood glucose detection technology integrates modern bioelectronics technology and traditional Chinese medicine wisdom, achieving a breakthrough from invasive to non-invasive blood glucose detection, which has a profound impact on the prevention and treatment of diabetes in China and is a milestone in the development of modern detection technology. This technology has obtained a national invention patent with the patent number ZL 2015 1 0435515.9. In addition, products such as multi-functional health detectors and inspection test strips/pens for genetically modified foods and organic foods also provide more diversified detection options for the market.
The company's core product, the non-invasive blood glucose detection technology, is the result of years of scientific research and development. This technology is based on bio-electrical signal processing technology. By stimulating specific areas of the human body, it collects physiological parameters such as bio-electrical signals, skin impedance, and skin humidity, and uses the company's unique patented algorithm and large model AI technology to calculate the instant blood glucose value accurately. Compared with traditional invasive detection methods, the non-invasive blood glucose monitoring technology not only avoids the pain and infection risks caused by blood collection, but also the accuracy of the detection results reaches international standards, bringing great convenience to the daily blood glucose management of diabetic patients.
Relying on the successful experience of non-invasive blood glucose monitoring technology, Top Biotechnology is actively laying out the future and fully developing non-invasive detection technologies for uric acid, glycosylated hemoglobin, blood ketone, etc. The non-invasive uric acid detection technology will provide convenient uric acid monitoring services for patients with gout and hyperuricemia, helping them adjust their living and treatment plans in a timely manner and effectively control the condition. The non-invasive glycosylated hemoglobin detection technology provides a new way for the evaluation of long-term blood glucose control effects in diabetic patients, helping doctors formulate more accurate treatment plans.
Strength witnessed, creating an industry benchmark brand
With strong R&D strength and rich industry experience, Top Biotechnology has achieved fruitful results in technological innovation and intellectual property protection, and has successfully applied for a number of patents. The company attaches great importance to open cooperation, actively conducts exchanges and cooperation with domestic and foreign scientific research institutions and enterprises, and promotes the collaborative development of the biotechnology industry.
Looking to the future, Top Biotechnology will always adhere to the development concept of "technology leading health, innovation achieving the future", continue to deeply cultivate the field of non-invasive detection technology, continuously break through technical bottlenecks, and launch more innovative products. The company is committed to becoming a leading enterprise in the global biotechnology field, creating more convenient and precise new health management solutions for chronic disease patients around the world, and enabling everyone to enjoy the health dividends brought by technology.